I am an ARC DECRA fellow at RegNet’s Justice and Technoscience (JusTech) laboratory, where I am developing an anti-racist neuroethics framework to promote epistemic justice in brain and mental health research.

I was previously an ANU-CSIRO postdoc in responsible innovation in precision health, where I investigated diversity, inclusivity, and equity considerations in health research, policy, promotion, and communication. Moreover, I am interested in determining the ethical, legal, regulatory, and societal issues in personalised and population health research involving culturally and linguistically diverse populations. My work involves engagement with laboratories/groups conducting biomedical/health research to investigate the perspectives of researchers on equity and diversity questions, to examine organisational cultures and social infrastructures that impact participant and researcher diversity, and to facilitate reflexive discussions among scientists on how to make their current and future projects more inclusive and culturally sensitive. The first three years of my postdoc was supported by both the Australian National Centre for the Public Awareness of Science at the Australian National University and the Responsible Innovation Future Science Platform of the Commonwealth Scientific and Industrial Research Organisation. I have also collaborated with researchers at CSIRO's Precision Health Future Science Platform and the Australian Centre for Disease Preparedness and colleagues at the ANU College of Health and Medicine and ANU College of Arts and Social Sciences.

In addition to my passion for equity, diversity, and justice in precision health research, I have a great interest in the societal aspects of neuroscience and biotechnology development. My PhD investigated ethical, legal, and societal issues associated with clinical trials of invasive neurosurgical procedures for people with Alzheimer's disease. Furthermore, I have worked on other bioethical issues such as media portrayal of novel technologies, application of new neuroimaging modalities, and patient experience and perception of neurotherapeutic interventions.